HR 6009 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Defense Biotechnology Strategy Act
To direct the Secretary of Defense to develop a strategy on the national security implications of emerging biotechnologies, and for other purposes.
Summary
The bill directs the Secretary of Defense to develop and submit a comprehensive strategy within one year on the national security implications of emerging biotechnologies and their role in defense. The strategy must address how the Department will develop biomanufacturing facilities, update military specifications to incorporate biotech products, establish market commitments for defense-related biotechnology, and strengthen international partnerships on biotechnology development. The strategy must also include plans for advanced research initiatives, regulatory frameworks, and coordination with NATO member countries on biotechnology procurement and research.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
2 cosponsors
Money behind the sponsor
Top reported contributors to Chrissy Houlahan’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $12,234
- GOOGLE $8,350
- UNIVERSITY OF PENNSYLVANIA $7,450
- SKADDEN ARPS $7,418
- LOWENSTEIN SANDLER LLP $7,350
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Chrissy Houlahan → · Outside spending →
Actions (2)
- Nov 10, 2025 Referred to the Committee on Armed Services, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- Nov 10, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
November 10, 2025
Ms. Houlahan (for herself and Mr. Sessions) introduced the following bill; which was referred to the Committee on Armed Services, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To direct the Secretary of Defense to develop a strategy on the national security implications of emerging biotechnologies, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Defense Biotechnology Strategy Act”.
SEC. 2. DEPARTMENT OF DEFENSE BIOTECHNOLOGY STRATEGY.
(a) In General.—Not later than 1 year after the date of enactment of this Act, the Secretary of Defense shall, in coordination with the Under Secretary of Defense for Research and Engineering and the Under Secretary of Defense for Acquisition and Sustainment, submit to the Committee on Armed Services of the Senate and the Committee on Armed Services of the House of Representatives a strategy on the national security implications of emerging biotechnologies, including the future role that biotechnology will play in defense, and means to improve industry, interagency, and international relationships in this sector.
(b) Elements.—The strategy required pursuant to subsection (a) shall include the following elements:
(1) How the Department of Defense will develop and expand a network of commercial facilities for the biomanufacture of products that are critical for defense needs.
(2) Review and update of military specifications in order to better incorporate or substitute current products with biotechnology-based products.
(3) Updated plans and policies for the Department to enter into advance market commitments and offtake agreements for biotechnology products that have defense applications.
(4) A description of how the Department could better incorporate military-relevant applications of emerging biotechnology into wargaming exercises, tabletop exercises, or other net assessment analyses.
(5) The benefits and costs of issuing a research grand challenge, or a series of challenges, that focus on making biotechnology predictably engineerable and how the Department would implement such research grand challenge, or challenges.
(6) Development of a biotechnology regulation science and technology program within the Department, including development of digital infrastructure to support simplified regulation and the development of biometrology tools.
(7) Updated plans and policies for inter-governmental support that the Department could provide in encouraging member countries of the North Atlantic Treaty Organization (NATO) to aggregate demand and pool purchasing power for biotechnology products.
(8) Review of plans and guidance on how the Department can work to develop, integrate, and disseminate biotechnology research initiatives across member countries of the North Atlantic Treaty Organization, and how the Department might coordinate with international stakeholders to utilize the combined research capabilities of such member countries to drive a biotechnology development approach. <all>
Comments